Eli Lilly & Company (NYSE: LLY)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $924.37
-
Support level$817.97
-
Resistance levelN/A
-
Beta0.7
-
RSI (14-day)81.0
- LLY is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- Up 7.1 percent, LLY is one of this week's biggest gainers.
- Volatility is forecast to fall over the next month.
- With RSI > 70, LLY is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $625.65 | $937.44 | 96.5% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $793.12 | $800.13 | $845.32 | $875.84 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week8.3%
-
In the next month18.2%
-
In the next year78.0%
| Period | Value |
|---|---|
| Historical (5 year) | 32.3% |
| Last month | 30.2% |
| Current estimate | 30.4% |
| Next month forecast | 32.2% |